Hanall Biopharma, a subsidiary of Daewoong Pharmaceutical, said it expanded the lineup of Biotop, over-the-counter probiotics.On Wednesday, Hanall Biopharma said it released Biotop Forte Cap. and Biotop Dual Cap.The existing Biotop series include Biotop D, a combination of lactic acid, butyric acid,
Amgen’s acute lymphoblastic leukemia (ALL) treatment Blincyto (ingredient: blinatumomab) passed the reimbursement review about two years after expanding indication to treat minimal residual disease (MRD) in patients with B-cell precursor ALL.In contrast, Amgen’s Xgeva (desonumab), which prevents ske
Professor Song Kyoung-ho of the Department of Infectious Disease at Seoul National University Bundang Hospital has been appointed an editor of Scientific Reports, an international academic journal.Scientific Reports is an online, open-access journal published by the Nature Publishing Group and a sis
Korea’s new virus cases exceeded 150,000 for the first time in four months on Wednesday, accompanied by sharp increases in severe cases and Covid-19 deaths, officials said.The country added 151,792 new Covid-19 infections, the highest since April 13, when it reported 195,387 cases, bringing the tota
Researchers at the Korea Research Institute of Biotechnology and Bioscience (KRIBB) have developed an ultra-small genetic scissor technology that significantly improved calibration efficiency.Genetic scissors technology removes, inserts, or replaces DNA from a specific base sequence in genes, as rep
T&R Biofab said Wednesday that it signed a strategic joint development agreement with Johnson & Johnson Innovation to develop the 3D bio-printing scaffold technology.According to T&R Biofab, the contract’s purpose is to develop an implantable product in the body based on diverse biomaterials and bio
Biogen dropped its plan to roll out Alzheimer’s disease treatment Aduhelm (ingredient: aducanumab) in Korea, sources said.The company reportedly told the Ministry of Food and Drug Safety that it would withdraw its application for Aduhelm approval.Earlier, the Central Pharmaceutical Affairs Council m
Ahead of the influenza season, Kwangdong Pharmaceutical said on Wednesday that it would start selling GSK’s quadrivalent flu vaccine, Fluarix Tetra, in Korea.Kwangdong has been handling the local distribution of Fluarix Tetra since last year. This year, the company plans to expand the vaccine distri
Since the inauguration of the Yoon Suk-yeol administration, the Minister of Health and Welfare has been vacant for 78 days as of Wednesday.Lawmakers worried about the long-term vacancy of the post, but the health and welfare ministry brushed aside such concerns.The National Assembly’s Health and Wel
Icure Pharmaceutical, a company specializing in drug delivery systems, has set about to expand oral incrementally modified drug (IMD) pipelines.The company said Wednesday that it had signed a technology transfer agreement with Hanall Biopharma on IMD for gastroesophageal reflux disease (GERD). Under
Deep Bio, an artificial intelligence-based digital pathology company, said on Wednesday that it agreed on partnerships with foreign companies to enter the overseas market with its prostate cancer diagnosis software, DeepDx Prostate.For starters, the company plans to expand its U.S. market share thro
The Ministry of Food and Drug Safety is expected to recall acetyl-L-carnitine (ALC), a cognitive function enhancer, and order drugmakers to stop making ALC-containing medicines in September, an MFDS official said.Shin Kyeong-seung, director of the MFDS’ pharmaceutical safety evaluation department, h
Korea's new Covid-19 cases jumped to a four-month high Tuesday due to summer vacation and increasing reinfections, the Korea Disease Control and Prevention Agency said.According to the KDCA, the country added 149,897 new Covid-19 infections, up from 55,292 the previous day and 111,785 a week earlier
LG Chem said it would enter the local wound dressing market, providing various skin care solutions from cosmetic fillers and skin boosters to wound dressings.The company said Monday it would start selling Kiomer-3 and Kiomer-Plus, wound dressing materials for medical professionals that are used to p
Eyegene said on Tuesday that it signed an agreement to develop a Japanese encephalitis virus gene-recombinant vaccine with financial support from the Korea Health Industry Development Institute (KHIDI).The research and development cost is estimated to be 200 million won ($150,000), and the state age
Idience said Tuesday that venadaparib, the company’s novel drug candidate for targeted agents, has been designated as an orphan drug by the U.S. Food and Drug Administration.Idience is a subsidiary of Ildong Holdings, the holding company of Ildong Pharmaceutical Group, specializing in novel drug dev
Hanmi Pharmaceutical said it was ready to lead the local dyslipidemia treatment market with Rosuzet (rosuvastatin 10mg+ezetimibe 10mg) because of the treatment’s “distinguished evidence for therapeutic benefits.”At a news conference in Seoul Monday, Hanmi disclosed the results of the RACING trial, s
The drug regulator is taking steps to revoke the indication of acetyl-L-carnitine, a cognitive function enhancer.On Friday, the Ministry of Food and Drug Safety suspended the prescription and dispensing of acetyl-L-carnitine-containing medicines and recommended using alternative drugs.Earlier, the M
MiCo BioMed, an in-vitro diagnostic medical device maker, said Tuesday that it completed the clinical trial of the monkeypox testing kit and applied for its export approval to the Ministry of Food and Drug Safety (MFDS).In July, the company conducted a clinical trial of a monkeypox PCR testing kit (
Pharmaceutical experts repeatedly said SK Bioscience’s Covid-19 vaccine SKYCovione needed additional safety review during the regulator’s marketing approval process, minutes of a drug review panel showed.The Ministry of Food and Drug Safety recently disclosed the minutes of the Central Pharmaceutica